In This Article:
NEW YORK, NY / ACCESSWIRE / August 30, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
WINS Shareholders Click Here: https://www.zlk.com/pslra-1/wins-finance-holdings-inc-loss-submission-form?prid=8924&wire=1
STAA Shareholders Click Here: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=8924&wire=1
VXRT Shareholders Click Here: https://www.zlk.com/pslra-1/vaxart-inc-information-request-form-2?prid=8924&wire=1
* ADDITIONAL INFORMATION BELOW *
Wins Finance Holdings Inc. (NASDAQ:WINS)
WINS Lawsuit on behalf of: investors who purchased October 31, 2018 - July 6, 2020
Lead Plaintiff Deadline : September 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/wins-finance-holdings-inc-loss-submission-form?prid=8924&wire=1
According to the filed complaint, during the class period, Wins Finance Holdings Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the ultimate repayment of the RMB 580 million Guohong Loan was highly uncertain; (ii) nonpayment of the Guohong Loan would have a significant impact on the Company's financial and operating condition; (iii) weaknesses in Wins's internal control over its financial reporting persisted despite the Company's repeated assurances to investors that it was taking steps to remediate these weaknesses; (iv) the foregoing issues, among others, made the resignation of Wins's independent auditor foreseeably likely; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Staar Surgical Company (NASDAQ:STAA)
STAA Lawsuit on behalf of: investors who purchased February 26, 2020 - August 10, 2020
Lead Plaintiff Deadline : October 19, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=8924&wire=1
According to the filed complaint, during the class period, Staar Surgical Company made materially false and/or misleading statements and/or failed to disclose that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.